4.2 Review

Neuropsychology of Multiple Sclerosis: Looking Back and Moving Forward

期刊

出版社

CAMBRIDGE UNIV PRESS
DOI: 10.1017/S1355617717000959

关键词

Multiple sclerosis; Neuropsychology; Cognition; Neuropathology; MRI; Gray matter; Rehabilitation

资金

  1. Abbvie
  2. Biogen
  3. EMD Serono
  4. Genentech
  5. Genzyme
  6. Novartis
  7. Roche
  8. Sanofi
  9. Consortium of MS Centers
  10. International Neuropsychological Society
  11. National Multiple Sclerosis Society
  12. Accorda
  13. National Institutes of Health
  14. U.S. Department of Defense
  15. Consortium of Multiple Sclerosis Centers
  16. Bayer Schering Pharma
  17. Merck Serono
  18. Shire
  19. Teva Pharmaceutical Industries Ltd./sanofi-aventis
  20. Dutch MS Research Foundation
  21. National MS Society
  22. Canadian MS Society
  23. Dutch Royal Society of the Arts Sciences
  24. Eisai
  25. Merck
  26. Pfizer
  27. Redhill pharmaceuticals
  28. Reata
  29. Gerson Lehman
  30. Lourie Foundation
  31. American Psychological Association
  32. CHDI Foundation

向作者/读者索取更多资源

The neuropsychological aspects of multiple sclerosis (MS) have evolved over the past three decades. What was once thought to be a rare occurrence, cognitive dysfunction is now viewed as one of the most disabling symptoms of the disease, with devastating effects on patients' quality of life. This selective review will highlight major innovations and scientific discoveries in the areas of neuropathology, neuroimaging, diagnosis, and treatment that pertain to our understanding of the neuropsychological aspects of MS. Specifically, we focus on the recent discovery that MS produces pathogical lesions of gray matter (GM) that have consequences for cognitive functions. Methods for imaging these GM lesions in MS are discussed along with multimodal imaging studies that integrate structural and functional imaging methods to provide a better understanding of the relationship between cognitive test performance and functional reserve. Innovations in the screening and comprehensive assessment of cognitive disorders are presented along with recent research that examines cognitive dysfunction in pediatric MS. Results of innovative outcome studies in cognitive rehabilitation are discussed. Finally, we highlight trends for potential future innovations over the next decade.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据